Jubilant Ingrevia Limited (NSE: JUBLINGREA)
India
· Delayed Price · Currency is INR | Market Cap | 112.93B |
| Revenue (ttm) | 40.85B |
| Net Income (ttm) | 1.74B |
| Shares Out | 157.99M |
| EPS (ttm) | 11.00 |
| PE Ratio | 64.99 |
| Forward PE | 38.27 |
| Dividend | 5.00 (0.70%) |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 852,551 |
| Open | 739.70 |
| Previous Close | 738.15 |
| Day's Range | 709.80 - 744.30 |
| 52-Week Range | 406.15 - 768.70 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 22, 2024 |
About Jubilant Ingrevia
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal... [Read more]
Financial Performance
In 2023, JUBLINGREA's revenue was 41.36 billion, a decrease of -13.34% compared to the previous year's 47.73 billion. Earnings were 1.83 billion, a decrease of -40.52%.
Financial StatementsNews
Jubilant Ingrevia Stock: Share price surges 6% this week after credit rating announcement
Jubilant Ingrevia saw its shares jump more than 6% this week after the company received positive credit ratings from India Ratings and Research. The ratings assigned were IND A1+ for a proposed commer...
Jubilant Ingrevia share price surges over 7% following credit rating announcement
On September 3, 2024, Jubilant Ingrevia Limited received positive credit ratings from India Ratings and Research, which has influenced the stock’s performance today. As of September 4, 2024, the stock...